Chapel Hill, NC, United States of America

Eric C Bigham

This inventor holds 18 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Burroughs Wellcome Co., Pfizer Corporation, Glaxo Wellcome Inc.. Active years: 1978-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eric C Bigham. Retrieved from https://idiyas.com/inventor/eric-c-bigham

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 94.4

Average Co-Inventor Count = 1.8

ph-index = 9

Forward Citations = 159(Granted Patents)


Location History:

  • Waterford, CT (US) (1978)
  • Chapel Hill, NC (US) (1981 - 2001)

Company Filing History:


Years Active: 1978-2001

Loading Chart...
Areas of Expertise:
Urea Derivatives
Isothiourea Derivatives
Isoquinolines
Neuromuscular Blockers
Antiviral Combinations
Glutamic Acid Derivatives
Biopterin Analogs
Penicillins
Methanediol
Azidomethylarylacetic Acids
18 patents (USPTO):Explore Patents

Title: Eric C Bigham: Innovator in Medicinal Chemistry

Introduction

Eric C Bigham is a prominent inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of medicinal chemistry, holding a total of 18 patents. His work primarily focuses on the development of novel compounds that have therapeutic applications.

Latest Patents

Among his latest patents, Bigham has developed substituted urea and isothiourea derivatives as nitric oxide synthase inhibitors. These compounds are particularly useful in the treatment of conditions such as cerebral ischemia. The patents detail the use of N-substituted urea derivatives for the manufacture of medicaments aimed at inhibiting the NO synthase enzyme. Additionally, the patents describe novel N-substituted urea derivatives and the processes for their preparation.

Career Highlights

Bigham has had a distinguished career, working with notable companies such as Burroughs Wellcome Co. and Pfizer Corporation. His experience in these organizations has allowed him to contribute to significant advancements in pharmaceutical development.

Collaborations

Throughout his career, Bigham has collaborated with esteemed colleagues, including Charles A Nichol and John F Reinhard, Jr. These partnerships have further enriched his research and innovation efforts.

Conclusion

Eric C Bigham's contributions to medicinal chemistry and his innovative patents highlight his role as a leading inventor in the field. His work continues to impact the development of therapeutic solutions for critical health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…